USFDA Inspection at Alembic Pharma's API facility at Karkhadi

This was a scheduled pre-approval inspection and at the end of the inspection, the USFDA issued a Form 483 with two observations, the company said.

from India Infoline News Service https://ift.tt/2Rzp5mh